Every day, thousands of consumers in the United States—including those with rare diseases or allergies to commercially available drugs—rely on specially and individually made medicines known as compounded drugs. Compounding is critically important for patients but, if done improperly, this process can pose significant risks to patients and healthcare workers alike. Patients could—and have—received contaminated drugs or preparations that are subpotent, contaminated, or super-potent. Healthcare workers, in turn, can face risks of exposure to hazardous drugs.
In the midst of a national epidemic of opioid abuse, our healthcare policymakers are trying to figure out how best to combat this intractable problem. According to the Centers for Disease Control and Prevention (CDC), opioids, (which include the prescription painkillers oxycodone, hydrocodone, morphine, and others) and the illegal drug heroin were involved in 28,647 overdose deaths in 2014. Drug overdose deaths are now the leading cause of injury-related death in the United States, even surpassing car crashes.